News Articles http://www.pharmaceuticalonline.com/ Wed, 08 Feb 2012 19:20:00 GMT Eriez® High Deflection (HD) Series Feeders are designed to handle products that normally can't be fed successfully on an electromagnetic feeder. Their totally enclosed patented magnetic drive enables feeding of practically any bulk material from micron size to bulky chunks. http://www.pharmaceuticalonline.com/article.mvc/Eriez-High-Deflection-HD-Series-Feeders-0001?atc~c=771+s=773+r=001+l=a Wed, 08 Feb 2012 19:20:00 GMT The Inert Gas Purge (IGP) system, available for use with most Genevac evaporators, enables safe operation even when working with highly explosive solvents, those with a low flash point, very low auto-ignition temperature and a wide explosive vapour saturation range. http://www.pharmaceuticalonline.com/article.mvc/Safe-Evaporation-Of-Diethyl-Ether-Assists-0001?atc~c=771+s=773+r=001+l=a Wed, 08 Feb 2012 08:26:00 GMT TSI Incorporated is pleased to announce a new range of Remote Particle Counters with 4-20 mA Analog Outputs. http://www.pharmaceuticalonline.com/article.mvc/TSI-Announces-New-Remote-Particle-Counters-0001?atc~c=771+s=773+r=001+l=a Wed, 08 Feb 2012 04:49:00 GMT Merck, known outside the United States and Canada as MSD, recently announced the top-line results of the TRA-2P (Thrombin Receptor Antagonist in Secondary Prevention of atherothrombotic ischemic events) study of vorapaxar. http://www.pharmaceuticalonline.com/article.mvc/Merck-Announces-Top-Line-Results-Of-TRA-2P-0001?atc~c=771+s=773+r=001+l=a Tue, 07 Feb 2012 13:30:00 GMT A clutch of promising Chinese companies in the formulation and delivery (F/D) market underlines the emergence of the Asian giant as a center for biopharma innovation and entrepreneurship, even as Western pharmaceutical companies continue to enjoy technological and business advantages, according to a Lux Research report titled, "The Expanding Formulation and Delivery Market in China." http://www.pharmaceuticalonline.com/article.mvc/China-Emerging-As-An-Innovation-Hub-For-0001?atc~c=771+s=773+r=001+l=a Tue, 07 Feb 2012 12:30:00 GMT Marken announced recently that it has recently received approval for its application for an expanded business license to allow the storage and distribution of clinical trial supplies and drug product in China. http://www.pharmaceuticalonline.com/article.mvc/Marken-Enhances-Presence-In-China-0001?atc~c=771+s=773+r=001+l=a Tue, 07 Feb 2012 08:19:00 GMT Brooks Life Science Systems, a division of Brooks Automation, Inc., a leading worldwide provider of automation solutions for compound and biological sample storage and management, recently announced the initiation of a technology development and commercialization partnership with The Scripps Research Institute (Scripps Research). http://www.pharmaceuticalonline.com/article.mvc/Brooks-Life-Science-Systems-And-The-Scripps-0001?atc~c=771+s=773+r=001+l=a Tue, 07 Feb 2012 08:00:00 GMT Siemens Healthcare Diagnostics announces two new companion diagnostics partnerships with pharmaceutical companies ViiV Healthcare and Tocagen - marking a major step for Siemens (NYSE: SI) into this important and fast-growing segment of the in vitro diagnostics (IVD) market. http://www.pharmaceuticalonline.com/article.mvc/Siemens-Forms-New-Companion-Diagnostics-0001?atc~c=771+s=773+r=001+l=a Tue, 07 Feb 2012 06:13:00 GMT Oliver Stauffer of PTI Inspection Systems will give a presentation on "Six Sigma Deployment for Complete Package Quality Control" during the HealthPack Conference for Medical Device Packaging in Albuquerque, New Mexico, March 6-8, 2012 at the Hyatt Regency. http://www.pharmaceuticalonline.com/article.mvc/Six-Sigma-Deployment-For-Complete-Package-0001?atc~c=771+s=773+r=001+l=a Tue, 07 Feb 2012 04:57:00 GMT Pharma and biotech experts from around the globe gathered in Las Vegas from January 25 to 27 for Drug Delivery Partnerships 2012 (DDP). Vegas seemed an appropriate location, because drug development is a high stakes game filled with risk and reward. http://www.pharmaceuticalonline.com/article.mvc/Drug-Delivery-Hits-It-Big-In-Vegas-0001?atc~c=771+s=773+r=001+l=a Mon, 06 Feb 2012 21:14:00 GMT Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that it has completed the divestiture of 1% clindamycin and 5% benzoyl peroxide gel (IDP-111), a generic version of Benzaclin, and 5% fluorouracil cream, (5-FU), an authorized generic of Efudex, to Mylan Inc. (Nasdaq: MYL). http://www.pharmaceuticalonline.com/article.mvc/Valeant-Pharmaceuticals-Completes-Divestiture-0001?atc~c=771+s=773+r=001+l=a Mon, 06 Feb 2012 07:31:00 GMT Materials characterization company Malvern Instruments focuses on 'smarter particle sizing' as the Mastersizer 3000 laser diffraction particle size analyzer makes its Pittcon debut in 2012 (Booth #3641 Pittcon 2012, 11-15 Mar 2012, Orlando, FL). http://www.pharmaceuticalonline.com/article.mvc/Smarter-Particle-Sizing-On-Malvern-Booth-At-0001?atc~c=771+s=773+r=001+l=a Mon, 06 Feb 2012 07:02:00 GMT Eriez' 5-Star Service helps eliminate or reduce equipment downtime by ensuring that customers' magnetic, vibratory and inspection processing equipment is quickly back in operation and functioning at peak performance. http://www.pharmaceuticalonline.com/article.mvc/Eriez-5-Star-Service-Provides-Regular-0001?atc~c=771+s=773+r=001+l=a Sun, 05 Feb 2012 08:24:00 GMT In response to investment community speculation following release of the transcript of a pre-trial conference call related to its Lidoderm® patent challenge, Watson Pharmaceuticals, Inc. (NYSE: WPI) today issued the following statement: http://www.pharmaceuticalonline.com/article.mvc/Watson-Provides-Update-On-Generic-Lidoderm-0001?atc~c=771+s=773+r=001+l=a Fri, 03 Feb 2012 07:44:00 GMT Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Laboratories Limited (formerly Matrix Laboratories Limited) has received tentative approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Atorvastatin Calcium Tablets, 10 mg (base), 20 mg (base), 40 mg (base) and 80 mg (base). http://www.pharmaceuticalonline.com/article.mvc/Mylan-Receives-Tentative-FDA-Approval-For-0001?atc~c=771+s=773+r=001+l=a Thu, 02 Feb 2012 11:10:00 GMT Bayer HealthCare, LLC today announced that the U.S. Food and Drug Administration agreed that Bayer can proceed with its expanded access program to provide the investigational drug radium-223 chloride to patients diagnosed with castration-resistant prostate cancer (CRPC)/hormone-refractory prostate cancer (HRPC) with symptomatic bone metastases. http://www.pharmaceuticalonline.com/article.mvc/Bayer-Initiates-Expanded-Access-Program-For-0001?atc~c=771+s=773+r=001+l=a Thu, 02 Feb 2012 11:00:00 GMT DelMar Pharma today announced that the United States FDA Office of Orphan Products Development has granted orphan drug designation for VAL-083 for the treatment of glioma, including glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer. http://www.pharmaceuticalonline.com/article.mvc/Del-Mar-Pharmaceuticals-Granted-US-Orphan-0001?atc~c=771+s=773+r=001+l=a Thu, 02 Feb 2012 10:36:00 GMT In conjunction with the publication of its full year 2011 results earlier recently, AstraZeneca announced new restructuring initiatives designed to improve productivity and strengthen the company's commercial, operations and research and development capabilities. http://www.pharmaceuticalonline.com/article.mvc/AstraZenecas-New-Restructuring-Initiatives-0001?atc~c=771+s=773+r=001+l=a Thu, 02 Feb 2012 10:25:00 GMT Norwich Clinical Services (NCS), a global provider of clinical research services for the pharmaceutical and biotech industries, recently announced a significant expansion to its clinical research capabilities in order to meet growing market demand. http://www.pharmaceuticalonline.com/article.mvc/Norwich-Expands-Capabilities-For-Phase-I-III-0001?atc~c=771+s=773+r=001+l=a Thu, 02 Feb 2012 10:12:00 GMT SAFEBRIDGE CONSULTANTS, INC. ("SafeBridge"), headquartered in Mountain View, California, has announced that Excella GmbH ("Excella") in Feucht, Germany has met the criteria established under the SafeBridge program for "Potent Compound Safety Certification" and has been deemed competent and proficient in the safe handling of potent active pharmaceutical ingredients ("APIs") at their chemical plant located in Feucht. http://www.pharmaceuticalonline.com/article.mvc/EXCELLA-GmbH-API-Plant-Achieves-SafeBridge-0001?atc~c=771+s=773+r=001+l=a Thu, 02 Feb 2012 09:57:00 GMT